ACT CAPITAL MANAGEMENT, LLC — 13F Holdings & Portfolio
CIK 1442273 · latest 13F-HR filed 2026-07-29
ACT CAPITAL MANAGEMENT, LLC manages $153.1M in 13F-reported U.S. long-equity assets across 62 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are KRYS (10.93%), TGTX (9.01%), ABVX (8.44%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 20 new positions and exited 14; 24 existing positions rose in reported value and 15 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-07-29
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
3 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 66%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Oct 23, 2026.
ASHEVILLE, NC 28801
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| ENGLISH, DOUGLAS, BARRY Control | MANAGING MEMBER since Oct 2014 | 75% or more | Individual |
| ENGLISH, JENNIFER, REALE Control | CHIEF COMPLIANCE OFFICER since Oct 2014 | Less than 5% | Individual |
| JOHNSON, ROGER, WESLEY Control | MANAGING MEMBER since Oct 2014 | 10–25% | Individual |
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- TG THERAPEUTICS INC$5.5M +66.7%
- ABIVAX SA$5.0M +63.7%
- ARROWHEAD PHARMACEUTICALS INC$3.8M +73.5%
- NUVATION BIO INC$1.7M +137.4%
- BLOOM ENERGY CORP$1.7M +272.4%
Top Trims
- CELCUITY INC-$4.0M -37.9%
- AMAZON.COM INC-$3.8M -55.3%
- CHEVRON CORP-$3.1M -19.9%
- ALUMIS INC-$2.4M -62.2%
- APPLIED OPTOELECTRONICS INC-$1.3M -59.4%
New Positions
- TESLA INC$4.5M
- AST SPACEMOBILE INC$3.9M
- PALVELLA THERAPEUTICS INC$3.4M
- NEBIUS GROUP NV$1.9M
- AMBARELLA INC$1.4M
Exited Positions
- STAAR SURGICAL CO$1.0M
- SENTINELONE INC$699.4K
- LUMENTUM HLDGS INC$632.5K
- CIRCLE INTERNET GROUP INC$572.5K
- NVIDIA CORPORATION$488.3K
ACT CAPITAL MANAGEMENT, LLC Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | KRYSTAL BIOTECH INC | KRYS | 501147102 | $16.7M | 10.93% | 45,000 | SH |
| 2 | TG THERAPEUTICS INC | TGTX | 88322Q108 | $13.8M | 9.01% | 251,025 | SH |
| 3 | ABIVAX SA | ABVX | 00370M103 | $12.9M | 8.44% | 97,000 | SH |
| 4 | CHEVRON CORP | CVX | 166764100 | $12.4M | 8.12% | 75,000 | SH |
| 5 | EXXON MOBIL CORP | XOM | 30231G102 | $10.7M | 7.01% | 78,500 | SH |
| 6 | ARROWHEAD PHARMACEUTICALS INC | ARWR | 04280A100 | $9.0M | 5.86% | 110,100 | SH |
| 7 | VIKING THERAPEUTICS INC | VKTX | 92686J106 | $8.2M | 5.33% | 209,300 | SH |
| 8 | CELCUITY INC | CELC | 15102K100 | $6.5M | 4.25% | 62,150 | SH |
| 9 | NEKTAR THERAPEUTICS | NKTR | 640268306 | $6.2M | 4.07% | 89,300 | SH |
| 10 | TESLA INC | TSLA | 88160R101 | $4.5M | 2.97% | 10,800 | SH |
| 11 | CYTOKINETICS INC | CYTK | 23282W605 | $4.0M | 2.64% | 47,500 | SH |
| 12 | AST SPACEMOBILE INC | ASTS | 00217D100 | $3.9M | 2.53% | 43,500 | SH |
| 13 | PALVELLA THERAPEUTICS INC | PVLA | 697947109 | $3.4M | 2.25% | 22,500 | SH |
| 14 | AMAZON.COM INC | AMZN | 023135106 | $3.1M | 2.01% | 12,900 | SH |
| 15 | NUVATION BIO INC | NUVB | 67080N101 | $3.0M | 1.93% | 520,000 | SH |
| 16 | XENON PHARMACEUTICALS INC | XENE | 98420N105 | $2.9M | 1.89% | 48,000 | SH |
| 17 | ENERGY TRANSFER L P | ET | 29273V100 | $2.5M | 1.66% | 133,100 | SH |
| 18 | BLOOM ENERGY CORP | BE | 093712107 | $2.3M | 1.48% | 7,500 | SH |
| 19 | FREEPORT-MCMORAN INC | FCX | 35671D857 | $2.0M | 1.34% | 32,500 | SH |
| 20 | NEBIUS GROUP NV | NBIS | N97284108 | $1.9M | 1.23% | 6,800 | SH |
| 21 | ALUMIS INC | ALMS | 022307102 | $1.5M | 0.95% | 51,600 | SH |
| 22 | AMBARELLA INC | AMBA | G037AX101 | $1.4M | 0.90% | 16,000 | SH |
| 23 | CEREBRAS SYSTEMS INC | CBRS | 15675D103 | $1.2M | 0.81% | 5,600 | SH |
| 24 | DEFINIUM THERAPEUTICS INC | DFTX | 24477V105 | $1.2M | 0.77% | 25,000 | SH |
| 25 | NOKIA CORP | NOK | 654902204 | $1.1M | 0.71% | 82,000 | SH |
| 26 | KURA ONCOLOGY INC | KURA | 50127T109 | $975.2K | 0.64% | 88,900 | SH |
| 27 | PRAXIS PRECISION MEDICINES INC | PRAX | 74006W207 | $903.9K | 0.59% | 2,700 | SH |
| 28 | APPLIED OPTOELECTRONICS INC | AAOI | 03823U102 | $889.0K | 0.58% | 6,000 | SH |
| 29 | CAMECO CORP | CCJ | 13321L108 | $855.6K | 0.56% | 8,400 | SH |
| 30 | MONTE ROSA THERAPEUTICS INC | GLUE | 61225M102 | $847.0K | 0.55% | 35,000 | SH |
| 31 | REGENXBIO INC | RGNX | 75901B107 | $808.6K | 0.53% | 67,500 | SH |
| 32 | MINERALYS THERAPEUTICS INC | MLYS | 603170101 | $758.1K | 0.50% | 28,100 | SH |
| 33 | GRAYSCALE BITCOIN TRUST ETF | GBTC | 389637109 | $701.0K | 0.46% | 15,400 | SH |
| 34 | VIR BIOTECHNOLOGY INC | VIR | 92764N102 | $655.2K | 0.43% | 64,300 | SH |
| 35 | PALISADE BIO INC | PALI | 696389402 | $642.7K | 0.42% | 307,500 | SH |
| 36 | PALANTIR TECHNOLOGIES INC | PLTR | 69608A108 | $641.7K | 0.42% | 5,500 | SH |
| 37 | ON SEMICONDUCTOR CORP | ON | 682189105 | $567.2K | 0.37% | 6,000 | SH |
| 38 | WARRIOR MET COAL INC | HCC | 93627C101 | $487.0K | 0.32% | 6,000 | SH |
| 39 | CRESCENT ENERGY COMPANY | CRGY | 44952J104 | $441.9K | 0.29% | 45,000 | SH |
| 40 | MBX BIOSCIENCES INC | MBX | 55287L101 | $441.6K | 0.29% | 8,000 | SH |
| 41 | KEEL INFRASTRUCTURE CORP | KEEL | 486917107 | $427.6K | 0.28% | 74,500 | SH |
| 42 | COMPASS PATHWAYS PLC | CMPS | 20451W101 | $424.5K | 0.28% | 30,000 | SH |
| 43 | CORVUS PHARMACEUTICALS INC | CRVS | 221015100 | $403.4K | 0.26% | 27,000 | SH |
| 44 | ALPHA COGNITION INC | ACOG | 02074J501 | $371.8K | 0.24% | 51,500 | SH |
| 45 | KYVERNA THERAPEUTICS INC | KYTX | 501976104 | $356.4K | 0.23% | 40,000 | SH |
| 46 | AXT INC | AXTI | 00246W103 | $353.2K | 0.23% | 4,900 | SH |
| 47 | INFLEQTION INC | INFQ | 45676K103 | $333.0K | 0.22% | 25,000 | SH |
| 48 | SCHOLAR ROCK HLDG CORP | SRRK | 80706P103 | $330.0K | 0.22% | 6,000 | SH |
| 49 | UIPATH INC | PATH | 90364P105 | $326.1K | 0.21% | 30,000 | SH |
| 50 | ADLAI NORTYE LTD | ANL | 00704R109 | $310.5K | 0.20% | 27,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-07-29 | $153.1M | 62 | 0001636587-26-000064 |
| 2026-03-31 | 2026-05-08 | $127.2M | 56 | 0001636587-26-000028 |
| 2025-12-31 | 2026-02-17 | $123.7M | 59 | 0001636587-26-000006 |
SUITE 110
WAYNE, PA 19087